On August 20, 2024, Aimed Alliance released a new fact sheet on, “IRA, PDABs, & Orphan Drugs: How Price Setting Mechanisms May Harm Patients with Rare Disorders.” This new resource reviews how the Inflation Reduction Act and Prescription Drug Affordability Boards may impact patients with rare disorders in terms of access to treatments as well as the investment in and research into treatments for these conditions. The resource highlights considerations for state and federal legislators that can help mitigate the impact of these programs on patients with rare disorders.
Last Updated on August 20, 2024 by Aimed Alliance
